
Sign up to save your podcasts
Or
Lou Niles joins Being Patient Live Talks to discuss his experience taking part in the donanemab clinical trial. The monoclonal antibody drug was revealed to have promising results in late 2023 and is currently awaiting FDA approval.
4.6
99 ratings
Lou Niles joins Being Patient Live Talks to discuss his experience taking part in the donanemab clinical trial. The monoclonal antibody drug was revealed to have promising results in late 2023 and is currently awaiting FDA approval.
22,074 Listeners
111,917 Listeners
56,231 Listeners
3,529 Listeners
37 Listeners
66 Listeners
6,447 Listeners
28,473 Listeners
15,321 Listeners
20,562 Listeners
15 Listeners
8,054 Listeners
492 Listeners
1,392 Listeners
7,419 Listeners